Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chitosan coated clove oil-based nanoemulsion: An attractive option for oral delivery of leflunomide in rheumatoid arthritis
Moataz B. Zewail, Sanaa A. El‐Gizawy, Gihan F. Asaad, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123224-123224
Closed Access | Times Cited: 19

Showing 19 citing articles:

The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: Signaling pathway crosstalk
Nehal I. Rizk, Heba M. Midan, Gouda K. Helal, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154771-154771
Closed Access | Times Cited: 24
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155007-155007
Closed Access | Times Cited: 20
Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis
Bazla Siddiqui, Asim ur Rehman, Rabia Gul, et al.
Carbohydrate Polymers (2023) Vol. 327, pp. 121683-121683
Closed Access | Times Cited: 14
From diagnosis to resistance: a symphony of miRNAs in pheochromocytoma progression and treatment response
Elsayed G.E. Elsakka, Ahmed Elshafei, Mohamed A. Elkady, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 1957-1969
Closed Access | Times Cited: 13
Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma
Aya Salman, Sherif S. Abdel Mageed, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154947-154947
Closed Access | Times Cited: 12
Decoding the role of miRNAs in oral cancer pathogenesis: A focus on signaling pathways
Ahmed S. Doghish, Ahmed A. El-Husseiny, Emad Gamil Khidr, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154949-154949
Closed Access | Times Cited: 11
Pharmacological and immunomodulatory modes of action of medically important phytochemicals against arthritis: A molecular insight
Aqsa Aqsa, Shaukat Ali, Muhammad Summer, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 3
Oral linalool-based nanoemulsion of acalabrutinib for ameliorating its oral bioavailability and in vitro anticancer potential in T lymphoblast cell lines
Arti Shettiwar, Ujala Gupta, Essha Chatterjee, et al.
Colloid & Polymer Science (2024) Vol. 302, Iss. 10, pp. 1491-1511
Closed Access | Times Cited: 3
Innovations in Nanoemulsion Technology: Enhancing Drug Delivery for Oral, Parenteral, and Ophthalmic Applications
Shery Jacob, Fathima Sheik Kather, Sai H. S. Boddu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1333-1333
Open Access | Times Cited: 3
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease
Osama A. Mohammed, Mohammed S. Elballal, Ahmed A. El-Husseiny, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155023-155023
Closed Access | Times Cited: 10
Desosomes and desimicelles − a novel vesicular and micellar system for enhanced oral delivery of poorly soluble drug: Optimization of in vitro characteristics and in vivo performance
Abdelrahman R. Said, Gihan F. Asaad, Marwa E. Shabana, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 200, pp. 114324-114324
Closed Access | Times Cited: 1
Lipid-based nanocarriers: an attractive approach for rheumatoid arthritis management
Moataz B. Zewail, Ahmed S. Doghish, Hussein M. El‐Husseiny, et al.
Biomaterials Science (2024)
Closed Access | Times Cited: 1
Development of famotidine-loaded lecithin-chitosan nanoparticles for prolonged and efficient anti-gastric ulcer activity
Moataz B. Zewail, Sanaa A. El‐Gizawy, Gihan F. Asaad, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105196-105196
Closed Access | Times Cited: 4
Bioactive Paper Packaging for Extended Food Shelf Life
Anamaria Irimia, Carmen‐Mihaela Popescu
Coatings (2023) Vol. 13, Iss. 9, pp. 1658-1658
Open Access | Times Cited: 3
Advanced application of carbohydrate-based micro/nanoparticles for rheumatoid arthritis
Linxian Cui, Jin-Kui Pi, Boquan Qin, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131809-131809
Closed Access
Revolutionizing nanomedicine: Expanding horizons of nanoemulsions in drug delivery and beyond
Mohit Kumar, Nitasha Chauhan, Devesh Kumar, et al.
Journal of Dispersion Science and Technology (2024), pp. 1-26
Closed Access
Leflunomide nanocarriers: a new prospect of therapeutic applications
Mariam Zewail
Journal of Microencapsulation (2024), pp. 1-24
Closed Access
PEGylated lipid polymeric nanoparticles for management of rheumatoid arthritis
Moataz B. Zewail, Gihan F. Asaad, Marwa E. Shabana, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106242-106242
Closed Access
A reliable liquid chromatography-quadrupole time-of-flight mass spectrometry method for quantitation of teriflunomide, a metabolite of leflunomide in human plasma of rheumatoid arthritis patients
Kotha Rohith Chandra, Pothuraju Naresh, Kotla Kotesh, et al.
Analytical Chemistry Letters (2024) Vol. 14, Iss. 6, pp. 862-880
Closed Access
Page 1

Scroll to top